Moroccan patients had defects in intrinsic and innate immunity, predominantly MSMD (48%), with genetic variations in the IL12RB1, STAT1, IFNGR1, SPPL2A, TYK2, and TBX21 genes [13]. The gene discussed is SPPL2A; the disease is Mendelian susceptibility to mycobacterial diseases.